Memantine Hydrochloride Accord Healthcare

Memantine Hydrochloride, the active ingredient in Memantine Hydrochloride Accord Healthcare, is an NMDA receptor antagonist presented as an oral dosage form for oral use. It is indicated for the symptomatic treatment of moderate to severe Alzheimer’s disease in adults.

GNH USA supplies Memantine Hydrochloride Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch, ensuring reliable supply chains across multiple regions.

Memantine Hydrochloride acts on the glutamatergic pathway to modulate neuronal excitability in dementia. - Alzheimer’s disease (moderate to severe): helps maintain cognition and daily functioning. - Alzheimer’s disease (mild to moderate): may be used as adjunct therapy to improve symptoms. - Behavioral disturbances in Alzheimer’s disease: may reduce agitation and aggression.

Common Side Effects: - Dizziness: transient light‑headedness. - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Confusion: occasional disorientation. - Hypertension: elevated blood pressure readings. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Seizures: rare occurrence of convulsive episodes. - Hallucinations: visual or auditory disturbances. - Cardiac arrhythmias: irregular heart rhythms. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Elevated liver enzymes: signs of hepatic stress. - Suicidal thoughts: emergence of depressive ideation.

Memantine Hydrochloride should be used with caution in specific clinical situations. - Renal impairment: assess kidney function and adjust dosing if necessary. - Hepatic impairment: monitor liver enzymes regularly. - History of seizures: evaluate risk before initiating therapy. - Concurrent NMDA agonists: avoid combined use to prevent antagonistic effects. - Pregnancy: safety not established; weigh potential benefits against risks. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Memantine Hydrochloride can interact with several drug classes. Major Interactions (Avoid): - Amantadine: increased risk of neurotoxicity. - Ketamine: additive NMDA antagonism may enhance CNS depression. - Other NMDA antagonists: combined effect may lead to excessive inhibition. Moderate Interactions (Monitor Closely): - Antihypertensives: possible potentiation of blood‑pressure lowering. - Diuretics: may increase dehydration risk. - Anticholinergics: could worsen cognitive side effects.